Wednesday, January 1, 2014

A Review of Human Influenza A(H5N1) Cases in 2013


In 2013, 38 human cases of Influenza A(H5N1)  were reported from around the world. This number represents an 18% increase over the number of reported cases in 2012. Six countries reported cases in 2013, Bangladesh, Cambodia, China, Egypt, Indonesia, and Vietnam. Cambodia reported about 71% (27) of all cases reported in 2013.   In 2013, children younger than 10 years old represent about 63% of all cases. No human clusters were reported in 2013. Relative to other countries, Cambodia experienced the greatest percentage increase in human infections in a short period of time. The continued low frequency of reported infections does not eliminate H5N1 as a pandemic threat.  


Influenza A(H5N1), (often referred to “bird flu” or avian influenza or HPAI), is an emerging infectious disease. It was first detected in humans in Hong Kong in 1997. Since 2003, the World Health Organization (WHO) has been monitoring human outbreaks of H5N1. Through December 31, 2013, WHO has officially reported a total of 648 confirmed human cases of H5N1. The most current WHO summary report on H5N1 is Influenza at the human-animal interface: Summary and assessment as of 20 December 2013.  The most recent WHO time line of significant events associated with the H5N1 virus was last updated on December 17, 2012 (link).The following summary of human cases of H5N1 in 2013 is generally organized according to the outline presented previously in “H5N1 in 2012: The Year in Review”. (link)

Since 2003, 15 countries have reported human H5N1 cases to WHO (link). The count of WHO-confirmed H5N1 cases in 2013 is 38.  Compared to 2012, the number of H5N1 cases increased by about 18%. In 2013, 6 countries reported human cases of H5N1, Bangladesh (1 case), Cambodia (26), China (2), Egypt (4), Indonesia (3), and Vietnam (2). These same six countries were the only countries to report H5N1 cases in 2012. 

Geographic Distribution

More than 60% of the H5N1 cases reported in 2012 occurred in Egypt and Indonesia. In 2013, more than 60% of the H5N1 cases were reported from Cambodia. Between 2003 and 2012, Cambodia had only reported 21 cases. In  the 12 month period of  2013, Cambodia reported  26 H5N1 cases, more than doubling  the count of previously reported cases. Indonesia continues to lead the world in cumulative number of reported human H5N1 cases with 195.  Egypt is second with 173 reported cases.  Based on the total number of cases reported, Cambodia now exceeds China and Thailand in total count of cases. It now ranks fourth behind Indonesia, Egypt, and Vietnam.

Map: WHO map of countries (Administrative level 1) with human H5N1 cases in 2013.

 Map: All countries reporting human H5N1 cases since 2003. 

Map: The approximate geolocations of H5N1 cases in Cambodia from 2003-2013.

Gender Statistics

Of the 38 reported cases in 2013 19 were male and 19 were female, although in the past females outnumbered males among reported cases. Overall, females represent about 53% of all of the WHO-reported H5N1 cases where sex was noted.  In 2013, 12 of the males died as did an equal number of females (12). 

Age Statistics

In 2013, the age of H5N1 cases ranged from less than one year old to 58 years old with a median age of 6. Children under 10 years old were the most commonly infected individuals. Twenty-four (63%) of the 38 cases were less than 10 years old in age.
Graph: Comparison of H5N1 infections in 2012 and 2013 by age group.


Twenty-two of the 24 children in 2013 were reported from Cambodia.  Only two other children were reported, a four-year-old from Vietnam and a one-year-old from Bangladesh.  Among all H5N1 cases, the greatest number cases are children in the 0-10-years-old age group.

Graph: All H5N1 cases by age group, 2003 to 2013.

Mortality Statistics

Of the 38 cases in 2013, 24 died. The  case-fatality ratio (CFR) is .625 for the 2013 calendar year. Over the past several years the CFR has not appreciably decreased.  Although there is inter-year variability, the overall CFR for the 648 WHO reported cases is .59.

As in previous years, children continued to have a slightly better survival rate than infected adults.  The CFR for the 24 children under 10 years old is .54, while the CFR for the 14 individuals older than 10 years is .78.

With the 26 cases and 14  deaths, Cambodia now has the second highest CFR rate at .70. Among the countries reporting at least 25 H5N1 cases, only Indonesia, with a CFR of .84, exceeds the CFR in Cambodia.

Table: H5N1 mortality by age group in 2013.

Seasonality

As noted previously, human H5N1 cases do not randomly occur throughout the year, but the number of cases fluctuates in a pattern similar to that of seasonal influenza in the northern hemisphere (link). Below is a current graph of the month of onset for almost all of the worldwide confirmed cases since 2009.  

Graph: Monthly H5N1 case count, 2009 to 2013. 


H5N1 Clusters

All 38 cases reported to WHO in 2013 represent sporadic cases. No clusters, as defined by WHO, were identified in 2013.  A cluster is defined as two or more cases of confirmed, probable, or suspected Influenza A(H5N1) infections with onset of illness occurring within the same two-week period and who are in the same geographical area and/or are epidemiologically linked. (link)

Discussion

In summary, the 38 H5N1 cases reported in 2013 is a slight increase over 2012, but less than the highest yearly total of 115 cases in 2006.  The concentration of 27 cases in Cambodia including 24 infected children is unusual, and the lack of reported clusters in 2103 is notable as well. As noted in 2012,  there has been an observable trend of an increasing number of H5N1 infections among young children. That trend has continued in 2013 with 63 % of the cases being younger than 10 years old. Previous analyses suggested that this age group had a high recovery rate. However, the infected children in 2013 had much lower survival rate. The reason for low recovery rates in children in Cambodia deserved further research.

Gain of function research in 2011 demonstrated that, in theory, only a few genetic changes are necessary for H5N1 to become an aerosolized pandemic virus.  While media attention in 2013 has focused on the Middle East respiratory syndrome coronavirus and  the novel influenza virus  A(H7N9), H5N1 continues to a pandemic threat, even if it is not receiving media attention.

 

 

Acknowledgements and Notes

I thank all of the internet sources, posters at FluTrackers.com, and other internet disease trackers for their online efforts to follow and track H5N1 cases. Thanks are also due to open source journals and researchers who post full copies of their papers and data sets.

The data and information used here have been derived from numerous publicly available sources including WHO, various ministries of health, internet bloggers, internet forums, and other media reports available online through December 31, 2013. For some individual cases, specific details are lacking or conflicting information is presented in online reports. However, the information and graphics presented here are based on data which is believed to be reasonably accurate and current through December 31, 2013.

Friday, December 6, 2013

Tracking the MERS-CoV Outbreak

The World Health Organization (WHO) is charged with tracking outbreaks of novel diseases around the world. For novel disease outbreaks such as H5N1, H7N9, SARS, Middle East respiratory syndrome coronavirus (MERS-CoV),  etc., WHO does report cumulative updates of the counts and locations of cases providing that the member states comply with International Health Regulations (IHR) about timely reporting of cases.

However, WHO does not provide a publicly available line list of cases of these novel disease outbreaks.  Such line lists of cases with epidemiological and geographic information help researchers and the general public assess the potential danger of these novel outbreaks.   Through December 2, 2013, more than 170 confirmed and probable human cases of  MERS-CoV have been reported from 11 countries including France, Italy, Jordan, Kuwait, Oman, Qatar, Saudi Arabia, Spain, Tunisia,  the  United Arab Emirates and the United Kingdom. Members of FluTrackers.com have been compiling a line list of confirmed MERS-CoV cases since early in 2013.[1]

I have posted a concordance list of the WHO confirmed cases with the individually reported and tracked MERS-CoV cases by FluTrackers members at this link.[2] This concordance list provides a basis for the general public to obtain more detailed information about individual cases in order to assess for themselves the nature and geographic distribution of this novel coronavirus.

[1] 2012/2013 Case List of MoH/WHO Novel Coronavirus nCoV Announced Cases

[2] WHO MERS-CoV Case Concordance List (as of December 2, 2013)

Friday, October 11, 2013

The Pressing Need to Identify the Intermediate Hosts of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)



In an ahead-of-print article in Virology Journal [1], Cui and associates report the results of a study of the molecular evolution of DPP4, a cell-surface receptor, across the mammalian phylogeny.  Their analyses showed that the dN/dS value on the bat lineage (0.96) was four times greater than the mammalian average leading to the conclusion that Middle East respiratory syndrome coronavirus (MERS-CoV) ultimately has a bat-origin.

From the article –

Our analysis therefore suggests that the evolutionary lineage leading to current MERS-CoV co-evolved with bat hosts for an extended time period, eventually jumping species boundaries to infect humans and perhaps through an intermediate host. As such, the emergence of MERS-CoV may parallel that of the related SARS-CoV. Although one bat species, Taphozous erforatus, in Saudi Arabia has been found to harbour a small RdRp (RNA-Dependent RNA Polymerase) fragment of MERS-CoV, a larger viral sampling of bats and other animals with close exposure to humans, including dromedary camels . . . are clearly needed to better understand the viral transmission route. . . .


While bats may ultimately be the host reservoir for this coronavirus, the distribution of human infections throughout the Arabian Peninsula, among individuals of both genders, and various ages and occupations, indicates that there is some other intermediate host infecting the index cases and other sporadic cases in the region. The sooner the intermediate host is identified, the more likely that these outbreaks of MERS-CoV can be contained.


h/t bgw

Thursday, October 3, 2013

MERS-CoV Clusters in Saudi Arabia



As previously noted, at least seven clusters of Middle East respiratory syndrome coronavirus (MERS-CoV) cases have occurred in the Kingdom of Saudi Arabia (KSA) [1]. An additional eighth cluster can be inferred from official reports for the city of Medina [2]. Besides Medina, 3 clusters have been reported from Riyadh, and one each from Al Hofuf, Mecca, Asir Province (Bisha?), and Hafar Al-Batin. 

Besides these clusters, in July, the World Health Organization (WHO) reported laboratory confirmation of a female healthcare worker from Hafar Al-Batin  who had contact with a previously confirmed case [3]. The only prior confirmed case from Hafar Al-Batin  was a 16-year-old male who was reported to have died in June [4]. This would constitute another cluster from Hafar Al-Batin.

Since August 1, the KSA  Ministry of Health has reported at least seven individuals from Riyadh who were in contact with previously confirmed cases. Because of the lack of case details it is not possible to ascertain how many clusters of MERS-CoV cases may have occurred since then in Riyadh or are occurring there at this time.

The table below presents information on the location and potential number of cases associated with MERS-CoV clusters in the KSA using cluster numbers assigned by the CDC [5]. The maps shows the general areas where these clusters occurred.


Location of MERS-CoV Clusters in Saudi Arabia

Wednesday, October 2, 2013

MERS-CoV is a Threat to Healthcare Workers and Hospital Patients



Recently, the European Centre for Disease Prevention and Control (ECDC) produced a summary report on the status of the Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak for the 130+ cases that have been reported since March 2012 [1].

While epidemiological data about these cases are presented in this report, several aspects of the report need further elaboration and discussion. As discussed on a USA Center for Disease Control web page [2] and noted in the ECDC report,  human clusters are prevalent for this novel disease. At least 14 MERS-CoV clusters have been reported. Single clusters have been reported from several countries, France, Italy, Jordan, Tunisia, and the United Kingdom. And the Kingdom of Saudi Arabia, which has reported more than 100 MERS-CoV cases, has experienced at least seven cluster outbreaks in seven separate geographic areas.

The ECDC authors state

We identified 14 clusters of 2-34 cases, where the primary cases were identified or suspected. However, data quality on the clusters is weak. All of the known 14 primary cases in clusters were adult men (24-83 years old) who were most likely exposed on the Arabian Peninsula. Of 129 cases with available information on transmission, 33 (26 percent) were possible nosocomial transmissions, 15 of these cases were healthcare workers (HCW). 17 of the 23 cases reported as HCW were female.
Information on geographic clusters of cases can provide important insight for public health officials into the mode of transmission, the transmissibility of the novel pathogen, and the potential identification of the non-human reservoir of a pathogen. What is not mentioned by the ECDC authors is that about 50% of all reported MERS-CoV cases have occurred in a cluster as defined by the World Health Organization (WHO) [3]. What is also not mentioned by the ECDC authors is how the index cases in these clusters became infected. The non-human source of this coronavirus has yet to be identified.

Of greater concern is the fact that at least 33 cases may have resulted from nosocomial transmissions. Nosocomial infection is a result of pathogen transmission within a hospital or healthcare facility.  This means that these 30+ individuals, including healthcare workers, contracted MERS-CoV in a healthcare facility such as a hospital. They did not contract the disease from an intermediate animal source. Infections within a healthcare facility are associated with human-to-human transmission. 

Several reports indicate that at least nine of these nosocomial infections were hospital patients most likely with comorbidities.  However, more alarming is that a number of healthcare workers were also infected in the hospital or healthcare treatment facility. This means that the coronavirus is transmissible not just among elderly individuals with chronic diseases but also among healthy younger healthcare workers who should be aware of, and prepared for, the dangers of human-to-human transmission.

Discussion
 
The nature of the transmissibility of the MERS-CoV is not clear, but the fact that numerous clusters have been reported and that human-to-human transmission is occurring among both patients and healthcare workers in healthcare facilities is cause for serious concern and demonstrates a need for increased monitoring and surveillance for this novel disease.